Fig. 1
From: Danaparoid sodium-based anticoagulation therapy for portal vein thrombosis in cirrhosis patients
Protocol of danaparoid sodium-based anticoagulation therapy. a Patients received intravenous injection of 1250 units of danaparoid sodium twice daily for 2 weeks. Patients belonging to the combination therapy group received additional infusion of AT-III at 1500 units/day from day 1 to day 5 and from day 8 to day 12. PVT was evaluated by using contrast-enhanced computed tomography at the end of 2 weeks of treatment (between days 13 and 18). b Measurement of PVT volume. The thrombus was traced on an axial CECT image and the volume of the thrombus was calculated using a 3-dimensional image analysis system (Synapse Vincent Ver. 3 and Ver. 5; Fujifilm Medical Co., Tokyo, Japan)